US Stock MarketDetailed Quotes
TRVI Trevi Therapeutics
- 3.600
- +1.110+44.58%
Close Dec 12 16:00 ET
- 3.624
- +0.024+0.67%
Post 16:52 ET
276.72MMarket Cap-8.18P/E (TTM)
4.600High3.430Low63.73MVolume3.910Open2.490Pre Close262.46MTurnover133.42%Turnover RatioLossP/E (Static)76.87MShares4.60052wk High4.69P/B171.97MFloat Cap1.26052wk Low--Dividend TTM47.77MShs Float10.620Historical High--Div YieldTTM46.99%Amplitude0.460Historical Low4.117Avg Price1Lot Size
Trevi Therapeutics Stock Forum
Sign in to post a comment
$Trevi Therapeutics (TRVI.US)$ Can't fight the shorts :(
1
1
$Trevi Therapeutics (TRVI.US)$ go to 6 il be happy haha
$Trevi Therapeutics (TRVI.US)$ bounceing iff 9 emp thinking its a dip n rip hopefully
$Trevi Therapeutics (TRVI.US)$
Trevi Therapeutics Announces Positive Outcome from Sample Size Re-estimation Resulting in No Change to the Current Sample Size for the Phase 2b CORAL Trial in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough
Thursday, 12th December at 7:30 am
Independent Data Monitoring Statistician reaffirmed current sample size to remain at N=160
The trial has reached 75% of the targeted enrollment, and topline results continue to be expected in the first half of 20...
Trevi Therapeutics Announces Positive Outcome from Sample Size Re-estimation Resulting in No Change to the Current Sample Size for the Phase 2b CORAL Trial in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough
Thursday, 12th December at 7:30 am
Independent Data Monitoring Statistician reaffirmed current sample size to remain at N=160
The trial has reached 75% of the targeted enrollment, and topline results continue to be expected in the first half of 20...
3
1
$Trevi Therapeutics (TRVI.US)$ Reuters· just
Trevi Therapeutics Announces Positive Outcome From SAMPLE Size Re-Estimation Resulting in No Change to the Current SAMPLE Size for the Phase 2B Coral Trial in Idiopathic Pulmonary Fibrosis Patients With Chronic Cough
Trevi Therapeutics Announces Positive Outcome From SAMPLE Size Re-Estimation Resulting in No Change to the Current SAMPLE Size for the Phase 2B Coral Trial in Idiopathic Pulmonary Fibrosis Patients With Chronic Cough
3
14
$Trevi Therapeutics (TRVI.US)$ why would it drop so hard after good/neutral news? Doesn’t make logical sense to me but im new to this.
1
3
$Trevi Therapeutics (TRVI.US)$
Trevi Therapeutics Announces Positive Topline Results from Human Abuse Potential Study of Oral Nalbuphine
1 minute ago, 1:05 PM PST
Via PR Newswire
Statistically significant lower "Drug Liking" for the 81mg and 162mg doses of oral nalbuphine vs. butorphanol covering our clinical dose range
NEW HAVEN, Conn., Dec. 3, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Hadu...
Trevi Therapeutics Announces Positive Topline Results from Human Abuse Potential Study of Oral Nalbuphine
1 minute ago, 1:05 PM PST
Via PR Newswire
Statistically significant lower "Drug Liking" for the 81mg and 162mg doses of oral nalbuphine vs. butorphanol covering our clinical dose range
NEW HAVEN, Conn., Dec. 3, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Hadu...
No comment yet
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Trytosaveabit : Nope because they have market makers on their side! And they can use shares that don’t even exist! Hehehe!
s